Aurora Cannabis (ACB) to Release Earnings on Wednesday

Key Points

• Aurora Cannabis is scheduled to release its Q1 2026 earnings before the market opens on August 6th, with analysts predicting an earnings per share of $0.18 and revenue of $96.83 million.
• The company recently downgraded from a "hold" rating to a "sell" rating by Wall Street Zen, highlighting potential concerns regarding its financial performance.
• Jones Financial Companies Lllp significantly increased its stake in Aurora Cannabis by over 9,600%, now owning approximately 0.09% of the company after buying additional shares in the first quarter.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) is expected to announce its Q1 2026 earnings results before the market opens on Wednesday, August 6th. Analysts expect the company to announce earnings of $0.18 per share and revenue of $96.83 million for the quarter.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last issued its quarterly earnings data on Wednesday, June 18th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.04). Aurora Cannabis had a net margin of 1.32% and a return on equity of 0.13%. The company had revenue of $63.34 million for the quarter, compared to the consensus estimate of $88.85 million. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Aurora Cannabis Stock Up 1.1%

ACB stock traded up $0.05 during trading on Friday, reaching $4.48. 1,764,375 shares of the company traded hands, compared to its average volume of 949,247. Aurora Cannabis has a 12 month low of $3.42 and a 12 month high of $7.20. The business has a 50 day simple moving average of $4.89 and a 200 day simple moving average of $4.78. The company has a market capitalization of $251.98 million, a price-to-earnings ratio of 40.73 and a beta of 1.84. The company has a debt-to-equity ratio of 0.13, a quick ratio of 2.16 and a current ratio of 4.31.

Institutional Investors Weigh In On Aurora Cannabis

A hedge fund recently raised its stake in Aurora Cannabis stock. Goldman Sachs Group Inc. increased its position in shares of Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) by 4.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 743,903 shares of the company's stock after purchasing an additional 29,099 shares during the quarter. Goldman Sachs Group Inc. owned 1.32% of Aurora Cannabis worth $3,266,000 as of its most recent SEC filing. 47.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut Aurora Cannabis from a "hold" rating to a "sell" rating in a research note on Friday, July 18th.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.